Glenn Wright

Glenn Wright has extensive experience in the pharmaceutical and biotech industry, with a focus on market access and payer relations. Glenn is currently serving as the Vice President of Client Partnership at MMIT. Prior to their current role, they were the Senior Director of Payer Relations and Government Programs at Enzyvant, where they led efforts to prepare the marketplace for a tissue-based regenerative product and managed interactions with payers. Glenn also worked at Epizyme as the Executive Director and Head of US Market Access, where they spearheaded market access strategies. Before that, at TESARO, Inc., they held the positions of Senior Director and Director of Corporate Accounts, Market Access, where they managed national and regional account managers and developed contracting and access strategies. Glenn also served as the National Account Director for Raptor Pharmaceuticals and the Corporate Account Director at ARIAD Pharmaceuticals. Earlier in their career, they worked at Eisai and MGI Pharma in various strategic and management roles. Glenn began their career at Forest Laboratories, where they held roles of increasing responsibility in key accounts and sales management.

Glenn Wright completed their Master in Business Administration (MBA) with a field of study in Finance from the Florida Institute of Technology. Glenn pursued this degree from 1991 to 1997. Prior to that, Wright obtained a Bachelor of Science (BS) in Finance from the University of South Florida between 1984 and 1987. Preceding their university education, their high school education was completed at Guilderland High School, with the start and end years unspecified.